Strategic Research Institute Release: World Antibody Community To Convene At mAbs Discovery & Development Conference June 12-14, 2006 In San Francisco, CA

2006-05-12
合作抗体疫苗
SAN FRANCISCO, May 12 /PRNewswire/ -- The world antibody community will convene on June 12-14, 2006 in San Francisco to attend and network at the 5th annual "Antibody Discovery & Development" conference, part of AWS, announces Strategic Research Institute. The preliminary attendee list is now available - see below. The 2006 Antibody World Summit (AWS) features 3 concurrent conferences that permit attendees to choose among 3 sessions at any time, tripling the session options, networking opportunities, and attendance. Those attending will have opportunity to learn about the latest in antibody technologies, discovery & development, manufacturing & production, therapeutics and partnering topics from the industrial, academic, and financial communities. The featured conference track on DISCOVERY & DEVELOPMENT attracts a very broad and international constituency of pharma/biotech companies and antibody companies. Companies such as Amgen, Genentech, Pfizer, Vaccinex, Biogen Idec, Affitech, Execellin, Merck Research Laboratories, GlaxoSmithKline, Centocor, Seattle Genetics, Wyeth, Astrazeneca, Xencor, NIST, Texas Tech, Rice University, Cambridge Antibody, Eli Lilly & Company, Medarex, NIH, Genovac, Human Genome Sciences, CellGenesys, Sangamo Biosciences and others will be presenting the latest in antibody discovery, development, and business development. The first morning General Session keynote presentations include: -- Delivering on the Promise of Antibody Therapeutics, Jim Thomas, Ph.D., Vice President of Process & Analytical Sciences, Amgen -- Synthetic Human Antibodies in Development, Sachdev Sidhu, Ph.D., Department of Protein Engineering, Genentech -- Development of Mapatumumag (NGS-ETR1), Gilles Gallant, Ph.D., Vice President Clinical Oncology, Human Genome Sciences -- Antibody Discovery & Development -- mAbs in Oncology -- Antibody Manufacturing & Production To request a copy of the agenda or the PRELIMINARY ATTENDEE LIST or for additonal information, please contact Mark Alexay at malexay@srinstitute.com or call 212-967-0095 x251. Please include your name, title and full contact info. For more information on how to present a poster at AWS, please contact Glenn Pascual at gpascual@srinstitute.com. For more information on sponsorship & exhibition opportunities to augment your company's on-site exposure to prospective clients and collaborators, please contact Mark Alexay at malexay@srinstitute.com For more information on how to become a media partner, please contact Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com Strategic Research Institute CONTACT: Mark Alexay, of Strategic Research Institute,malexay@srinstitute.com, +1-212-967-0095 x251 Web site:
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。